Experts say it's common to wait until new teams are in place but is a concern if it means "going back to a prior approach of ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company focused on developing and commercializing novel therapies for difficult-to-treat cancers, has demonstrated resilience and growth potential in ...